Plus-U SRL
5.0 FTEThe score of Plus-U shows with a free account.
See the score- Summary? / 5
- Solvency
- Liquidity
- Interest coverage
- Profitability
- Leverage
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +28437 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Plus-U's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −461,668 € | ||||
| Equity | −676,049 € | ||||
| Cash | 2,727 € | ||||
| EBITDA | −439,974 € | ||||
| Total assets | €1.56m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 28 Jan 2025
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 21 Sep 2022
Plus-U's financial analysis
- Solvency-43.5%sector median: 46.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Plus-U
Plus-U's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0756.840.322
- VAT number
- BE0756840322
- Peppol
- Not found on Peppol as of 22 Oct 2026 · Check
- Legal form
- SRL
- Incorporated
- 21 Oct 2020
- Registered office
- 9000 Ghent
- Size
- Micro · 5.0 FTE
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Plus-U (SRL) has been based in Ghent since 2020, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 461,668 € and equity of −676,049 €; its revenue is not published. With 5.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -43.5%, below the median of its sector (46.6%).
Companies similar to Plus-U
Companies in the same business, of comparable size and area, outside its group.
- Ceres Pharmaceuticals Wholesale of pharmaceutical and medical goods Ghent · balance sheet €9.46m
- Opella Healthcare Belgium NV/SA Manufacture of pharmaceutical preparations Machelen (Brab.) · balance sheet €32.3m
- GE Healthcare Manufacture of medical and dental instruments and supplies Machelen (Brab.) · balance sheet €262.8m
- Hysop Wholesale of china and glassware and cleaning materials Kuurne · balance sheet €2.47m
- Melon-Wislez Wholesale of pharmaceutical and medical goods Waimes · balance sheet 901,346 €
- Farmafrance Retail sale of pharmaceutical products Halle · balance sheet €1.38m
- Pharmacie DU Lothier Activities of agents involved in the wholesale of furniture, household goods, hardware and ironmongery Genappe · balance sheet €1.09m
- Corswarem Solar Solutions Wholesale of china and glassware and cleaning materials Tongeren-Borgloon · balance sheet 900,713 €
Frequently asked questions about Plus-U
What is the revenue of Plus-U?
Plus-U files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Plus-U?
In Belgium, the VAT number is the company number prefixed with BE: BE0756840322 for Plus-U, if the company is VAT-registered. Its company number (CBE) is 0756.840.322.
Where is the registered office of Plus-U?
According to the CBE register, the registered office of Plus-U is in 9000 Ghent.
What is the equity of Plus-U?
At the close of the 2025 financial year, the equity of Plus-U amounts to -676,049 €, a solvency of -43.5% of total assets.
How many people work at Plus-U?
5.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Plus-U?
The register lists 6 active mandates at Plus-U. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Plus-U
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →